Description
Co-lyophilized two-component blend containing 5 mg synthetic thymosin beta-4 (43 aa) and 5 mg BPC-157 (15 aa) per vial.
| Compound | Thymosin beta-4 + BPC-157 |
|---|---|
| Form | Lyophilized powder, sealed vial |
| Contents | 10 vials per kit (5 mg + 5 mg per vial) |
| Purity | Third-party certificate in progress |
| Storage | Store lyophilized at −20 °C, protected from light and moisture |
All products listed on this site are for research purposes only. This product is intended strictly for laboratory, academic, or institutional research. It is not for human or animal consumption, dosing, injection, or ingestion, and is not a drug, food, cosmetic, or supplement.